{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:57:07Z","timestamp":1790049427393,"version":"4.0.1"},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T00:00:00Z","timestamp":1499040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["PO1 AI074286"],"award-info":[{"award-number":["PO1 AI074286"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI091031"],"award-info":[{"award-number":["U19 AI091031"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI102718"],"award-info":[{"award-number":["AI102718"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UO1 AI034994"],"award-info":[{"award-number":["UO1 AI034994"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UO1 AI034989"],"award-info":[{"award-number":["UO1 AI034989"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UO1 AI 042590"],"award-info":[{"award-number":["UO1 AI 042590"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0180245","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T17:34:12Z","timestamp":1499103252000},"page":"e0180245","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy"],"prefix":"10.1371","volume":"12","author":[{"given":"Rafiq","family":"Nabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zina","family":"Moldoveanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen G.","family":"Durkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy C.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek J.","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seble","family":"Kassaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Landay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Mestecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9906-6234","authenticated-orcid":true,"given":"Pamela A.","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2011.07.007","article-title":"HIV controllers: a multifactorial phenotype of spontaneous viral suppression","volume":"141","author":"J Theze","year":"2011","journal-title":"Clin Immunol"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nri3478","article-title":"Unravelling the mechanisms of durable control of HIV-1","volume":"13","author":"BD Walker","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"ref3","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.1128\/JVI.00980-10","article-title":"HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses","volume":"84","author":"AL Ferre","year":"2010","journal-title":"J Virol"},{"issue":"19","key":"ref4","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1128\/JVI.00056-12","article-title":"HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term","volume":"86","author":"B Vingert","year":"2012","journal-title":"J Virol"},{"issue":"19","key":"ref5","doi-asserted-by":"crossref","first-page":"10354","DOI":"10.1128\/JVI.00803-10","article-title":"Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers","volume":"84","author":"AL Ferre","year":"2010","journal-title":"J Virol"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"MR Betts","year":"2006","journal-title":"Blood"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/526786","article-title":"Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy","volume":"197","author":"F Pereyra","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"e58768","DOI":"10.1371\/journal.pone.0058768","article-title":"A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients","volume":"8","author":"C Brombin","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1128\/JVI.01482-09","article-title":"Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables","volume":"84","author":"NA Doria-Rose","year":"2010","journal-title":"J Virol"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","article-title":"Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers","volume":"23","author":"O Lambotte","year":"2009","journal-title":"AIDS"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"e1005315","DOI":"10.1371\/journal.ppat.1005315","article-title":"Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control","volume":"12","author":"ME Ackerman","year":"2016","journal-title":"PLoS Pathog"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/aid.1994.10.813","article-title":"Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals","volume":"10","author":"PA Kozlowski","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.4049\/jimmunol.152.9.4642","article-title":"Serum IgA-mediated neutralization of HIV type 1","volume":"152","author":"PR Burnett","year":"1994","journal-title":"J Immunol"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"e1005817","DOI":"10.1371\/journal.ppat.1005817","article-title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses","volume":"12","author":"MZ Tay","year":"2016","journal-title":"PLoS Pathog"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/clin.1996.0175","article-title":"Serum and secretory IgA from HIV-infected individuals mediate antibody-dependent cellular cytotoxicity","volume":"81","author":"KP Black","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4049\/jimmunol.1201469","article-title":"Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8","volume":"190","author":"X Yu","year":"2013","journal-title":"J Immunol"},{"issue":"17","key":"ref17","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.vaccine.2011.02.051","article-title":"Partial efficacy of a VSV-SIV\/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques","volume":"29","author":"ML Marthas","year":"2011","journal-title":"Vaccine"},{"key":"ref18","article-title":"Strong, but age-dependent, protection elicited by a DNA\/Modified vaccinia ankara simian immunodeficiency virus vaccine","author":"V Chamcha","year":"2016","journal-title":"Open Forum Infectious Diseases"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"e1006104","DOI":"10.1371\/journal.ppat.1006104","article-title":"Persistent Low-Level Replication of SIVDeltanef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection","volume":"12","author":"S Adnan","year":"2016","journal-title":"PLoS Pathog"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1089\/aid.1992.8.1773","article-title":"Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins","volume":"8","author":"PA Kozlowski","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1089\/aid.2004.20.972","article-title":"Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals","volume":"20","author":"J Mestecky","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/mi.2012.107","article-title":"HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life","volume":"6","author":"NL Yates","year":"2013","journal-title":"Mucosal Immunol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.chom.2014.07.003","article-title":"HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria","volume":"16","author":"AM Trama","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/JCM.22.2.259-264.1985","article-title":"Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans","volume":"22","author":"TA Brown","year":"1985","journal-title":"J Clin Microbiol"},{"issue":"17","key":"ref25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM196810242791701","article-title":"Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection","volume":"279","author":"PL Ogra","year":"1968","journal-title":"N Engl J Med"},{"key":"ref26","first-page":"799","article-title":"Mucosal Immunology","author":"BR Murphy","year":"2005"},{"key":"ref27","first-page":"1129","article-title":"Mucosal Immunology","author":"AJ Broadbent","year":"2015"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/ni.1753","article-title":"HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits","volume":"10","author":"W Xu","year":"2009","journal-title":"Nat Immunol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"e1006087","DOI":"10.1371\/journal.ppat.1006087","article-title":"Dysregulation of Systemic and Mucosal Humoral Responses to Microbial and Food Antigens as a Factor Contributing to Microbial Translocation and Chronic Inflammation in HIV-1 Infection","volume":"13","author":"Z Hel","year":"2017","journal-title":"PLoS Pathog"},{"issue":"17","key":"ref30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1089\/088922202320886334","article-title":"Detection of mucosal antibodies in HIV type 1-infected individuals","volume":"18","author":"PF Wright","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1128\/IAI.62.3.892-896.1994","article-title":"Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS","volume":"62","author":"MM Coogan","year":"1994","journal-title":"Infect Immun"},{"issue":"35","key":"ref32","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1016\/j.vaccine.2013.04.062","article-title":"Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults","volume":"31","author":"AM Collins","year":"2013","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2334-9-179","article-title":"Serum immunoglobulin G, M and A response to Cryptosporidium parvum in Cryptosporidium-HIV co-infected patients","volume":"9","author":"K Kaushik","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"6884","key":"ref34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"DC Douek","year":"2002","journal-title":"Nature"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1089\/aid.2016.0182","article-title":"Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort","volume":"32","author":"E Fink","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1128\/JVI.02363-15","article-title":"Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity","volume":"90","author":"MJ Ruiz","year":"2016","journal-title":"J Virol"},{"issue":"14","key":"ref37","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"issue":"22","key":"ref38","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"GD Tomaras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"e53629","DOI":"10.1371\/journal.pone.0053629","article-title":"Analysis of V2 antibody responses induced in vaccinees in the ALVAC\/AIDSVAX HIV-1 vaccine efficacy trial","volume":"8","author":"S Zolla-Pazner","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"e87572","DOI":"10.1371\/journal.pone.0087572","article-title":"Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection","volume":"9","author":"S Zolla-Pazner","year":"2014","journal-title":"PLoS One"},{"issue":"9293","key":"ref41","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(01)06653-3","article-title":"Determinants of HIV-1 shedding in the genital tract of women","volume":"358","author":"A Kovacs","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/COH.0b013e328344f35e","article-title":"Epidemiology and clinical characteristics of elite controllers","volume":"6","author":"JF Okulicz","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1211s64","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays","author":"DC Montefiori","year":"2005","journal-title":"Curr Protoc Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/1874613601206010293","article-title":"Comparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women","volume":"6","author":"Q Wei","year":"2012","journal-title":"Open AIDS J"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/aid.2010.0169","article-title":"Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women","volume":"27","author":"J Mestecky","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"19","key":"ref46","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0264-410X(98)00182-0","article-title":"Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1\/V2 domain of HIV-1 gp120","volume":"16","author":"A Pinter","year":"1998","journal-title":"Vaccine"},{"issue":"20","key":"ref47","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1073\/pnas.201392898","article-title":"Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region","volume":"98","author":"DM Eckert","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6249","key":"ref48","doi-asserted-by":"crossref","first-page":"aab1253","DOI":"10.1126\/science.aab1253","article-title":"HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies","volume":"349","author":"WB Williams","year":"2015","journal-title":"Science"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nri1307","article-title":"Identifying epitopes of HIV-1 that induce protective antibodies","volume":"4","author":"S Zolla-Pazner","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"e18233","DOI":"10.1371\/journal.pone.0018233","article-title":"HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies","volume":"6","author":"J Wang","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00042560-200008010-00001","article-title":"Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody","volume":"24","author":"PA Kozlowski","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"19","key":"ref52","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1128\/JVI.01163-16","article-title":"Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA\/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques","volume":"90","author":"SS Iyer","year":"2016","journal-title":"J Virol"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virol.2007.07.017","article-title":"GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA\/MVA immunodeficiency virus vaccine","volume":"369","author":"L Lai","year":"2007","journal-title":"Virology"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00401706.1964.10490181","article-title":"Multiple comparisons using rank sums","volume":"6","author":"OJ Dunn","year":"1964","journal-title":"Technometrics"},{"issue":"1","key":"ref55","first-page":"15","article-title":"HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket","volume":"14","author":"C Pastori","year":"2000","journal-title":"J Biol Regul Homeost Agents"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.4049\/jimmunol.172.4.2401","article-title":"Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface","volume":"172","author":"T Yamada","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"ref57","first-page":"15","article-title":"Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users","volume":"6","author":"G Rezza","year":"1992","journal-title":"J Biol Regul Homeost Agents"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/JVI.03130-13","article-title":"Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers","volume":"88","author":"JI Lai","year":"2014","journal-title":"J Virol"},{"issue":"24","key":"ref59","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"GD Tomaras","year":"2008","journal-title":"J Virol"},{"issue":"11","key":"ref60","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1084\/jem.20110363","article-title":"Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated","volume":"208","author":"HX Liao","year":"2011","journal-title":"J Exp Med"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys","volume":"155","author":"DH Barouch","year":"2013","journal-title":"Cell"},{"issue":"4","key":"ref62","article-title":"Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5alpha","volume":"91","author":"SP Kasturi","year":"2017","journal-title":"Restrictive Macaques. J Virol"},{"issue":"12","key":"ref63","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1128\/JVI.02625-05","article-title":"Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells","volume":"80","author":"V Holl","year":"2006","journal-title":"J Virol"},{"issue":"8","key":"ref64","doi-asserted-by":"crossref","first-page":"e1005042","DOI":"10.1371\/journal.ppat.1005042","article-title":"Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques","volume":"11","author":"S Santra","year":"2015","journal-title":"PLoS Pathog"},{"issue":"10","key":"ref65","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.4049\/jimmunol.145.10.3276","article-title":"Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies","volume":"145","author":"DS Tyler","year":"1990","journal-title":"J Immunol"},{"issue":"27","key":"ref66","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.1073\/pnas.1103012108","article-title":"Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody","volume":"108","author":"DR Burton","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/mi.2013.23","article-title":"Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques","volume":"7","author":"C Moog","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ni1566","article-title":"HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells","volume":"9","author":"J Arthos","year":"2008","journal-title":"Nat Immunol"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/aid.2007.0187","article-title":"Opposite immune reactivity of serum IgG and secretory IgA to conformational recombinant proteins mimicking V1\/V2 domains of three different HIV type 1 subtypes depending on glycosylation","volume":"24","author":"V Granados-Gonzalez","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"ref70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/icb.2013.54","article-title":"Gut TFH and IgA: key players for regulation of bacterial communities and immune homeostasis","volume":"92","author":"LM Kato","year":"2014","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"ref71","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/mi.2014.134","article-title":"Interleukin (IL)-21 promotes intestinal IgA response to microbiota","volume":"8","author":"AT Cao","year":"2015","journal-title":"Mucosal Immunol"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ni.2552","article-title":"Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses","volume":"14","author":"K Hirota","year":"2013","journal-title":"Nat Immunol"},{"key":"ref73","article-title":"Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses","author":"D Christensen","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"12","key":"ref74","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/eji.200939498","article-title":"Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways","volume":"39","author":"Z Jaffar","year":"2009","journal-title":"Eur J Immunol"},{"issue":"3","key":"ref75","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.4049\/jimmunol.0903058","article-title":"Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection","volume":"184","author":"A Gosselin","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"ref76","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4049\/jimmunol.1101592","article-title":"Human CD90 identifies Th17\/Tc17 T cell subsets that are depleted in HIV-infected patients","volume":"188","author":"M Guillot-Delost","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"ref77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/651021","article-title":"Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection","volume":"201","author":"A El Hed","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"ref78","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/QAI.0000000000000389","article-title":"Early HIV-1 infection is associated with reduced frequencies of cervical Th17 cells","volume":"68","author":"LR McKinnon","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"ref79","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood-2008-05-159301","article-title":"Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections","volume":"112","author":"JM Brenchley","year":"2008","journal-title":"Blood"},{"issue":"4","key":"ref80","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/imm.12527","article-title":"Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells","volume":"146","author":"L Masson","year":"2015","journal-title":"Immunology"},{"issue":"32","key":"ref81","doi-asserted-by":"crossref","first-page":"32ra6","DOI":"10.1126\/scitranslmed.3000632","article-title":"Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease","volume":"2","author":"D Favre","year":"2010","journal-title":"Sci Transl Med"},{"issue":"1","key":"ref82","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QAI.0b013e3182a7c932","article-title":"Immunoregulatory T cells may be involved in preserving CD4 T cell counts in HIV-infected long-term nonprogressors and controllers","volume":"65","author":"JC Gaardbo","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"ref83","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.2011.04435.x","article-title":"Loss of balance between T helper type 17 and regulatory T cells in chronic human immunodeficiency virus infection","volume":"165","author":"D Li","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"ref84","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1128\/JVI.02643-10","article-title":"CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors","volume":"85","author":"EJ Ciccone","year":"2011","journal-title":"J Virol"},{"issue":"5","key":"ref85","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/gut.50.5.608","article-title":"Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques","volume":"50","author":"F Schafer","year":"2002","journal-title":"Gut"},{"issue":"9","key":"ref86","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.vaccine.2011.12.026","article-title":"SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses","volume":"30","author":"L Lai","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"ref87","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.4049\/jimmunol.1600143","article-title":"Induction of Th1-Biased T Follicular Helper (Tfh) Cells in Lymphoid Tissues during Chronic Simian Immunodeficiency Virus Infection Defines Functionally Distinct Germinal Center Tfh Cells","volume":"197","author":"V Velu","year":"2016","journal-title":"J Immunol"},{"issue":"17","key":"ref88","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1182\/blood-2008-10-182709","article-title":"Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control","volume":"113","author":"AL Ferre","year":"2009","journal-title":"Blood"},{"issue":"6","key":"ref89","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-3083.2008.02184.x","article-title":"Residual viraemia in HIV-1-infected patients with plasma viral load <or = 20 copies\/ml is associated with increased blood levels of soluble immune activation markers","volume":"68","author":"SR Ostrowski","year":"2008","journal-title":"Scand J Immunol"},{"issue":"3","key":"ref90","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAD.0b013e32834273ad","article-title":"Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation","volume":"25","author":"DL Regidor","year":"2011","journal-title":"AIDS"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0180245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T08:20:37Z","timestamp":1692865237000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0180245"}},"subtitle":[],"editor":[{"given":"Aftab A.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,3]]},"references-count":90,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0180245","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,3]]}}}